|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:ANXA1-U2SURP (FusionGDB2 ID:5111) |
Fusion Gene Summary for ANXA1-U2SURP |
Fusion gene summary |
Fusion gene information | Fusion gene name: ANXA1-U2SURP | Fusion gene ID: 5111 | Hgene | Tgene | Gene symbol | ANXA1 | U2SURP | Gene ID | 301 | 23350 |
Gene name | annexin A1 | U2 snRNP associated SURP domain containing | |
Synonyms | ANX1|LPC1 | SR140|fSAPa | |
Cytomap | 9q21.13 | 3q23 | |
Type of gene | protein-coding | protein-coding | |
Description | annexin A1annexin I (lipocortin I)annexin-1calpactin IIcalpactin-2chromobindin-9epididymis secretory sperm binding proteinphospholipase A2 inhibitory protein | U2 snRNP-associated SURP motif-containing protein140 kDa Ser/Arg-rich domain proteinSer/Arg-rich domain protein, 140 kDaU2-associated SR140 proteinU2-associated protein SR140functional spliceosome-associated protein a | |
Modification date | 20200329 | 20200313 | |
UniProtAcc | P04083 | . | |
Ensembl transtripts involved in fusion gene | ENST00000257497, ENST00000376911, ENST00000491192, | ENST00000397933, ENST00000473835, ENST00000493598, | |
Fusion gene scores | * DoF score | 6 X 6 X 3=108 | 9 X 10 X 3=270 |
# samples | 6 | 11 | |
** MAII score | log2(6/108*10)=-0.84799690655495 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(11/270*10)=-1.29545588352617 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: ANXA1 [Title/Abstract] AND U2SURP [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | ANXA1(75775236)-U2SURP(142769845), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | ANXA1 | GO:0002548 | monocyte chemotaxis | 15187149 |
Hgene | ANXA1 | GO:0007187 | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 25664854 |
Hgene | ANXA1 | GO:0008360 | regulation of cell shape | 15187149 |
Hgene | ANXA1 | GO:0018149 | peptide cross-linking | 10908733 |
Hgene | ANXA1 | GO:0030216 | keratinocyte differentiation | 10908733 |
Hgene | ANXA1 | GO:0031340 | positive regulation of vesicle fusion | 2138016 |
Hgene | ANXA1 | GO:0031532 | actin cytoskeleton reorganization | 15187149 |
Hgene | ANXA1 | GO:0032743 | positive regulation of interleukin-2 production | 17008549 |
Hgene | ANXA1 | GO:0035924 | cellular response to vascular endothelial growth factor stimulus | 22773844 |
Hgene | ANXA1 | GO:0042102 | positive regulation of T cell proliferation | 17008549 |
Hgene | ANXA1 | GO:0045627 | positive regulation of T-helper 1 cell differentiation | 17008549 |
Hgene | ANXA1 | GO:0045629 | negative regulation of T-helper 2 cell differentiation | 17008549 |
Hgene | ANXA1 | GO:0071385 | cellular response to glucocorticoid stimulus | 2936963 |
Hgene | ANXA1 | GO:0071621 | granulocyte chemotaxis | 15187149 |
Hgene | ANXA1 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis | 22773844 |
Hgene | ANXA1 | GO:0090303 | positive regulation of wound healing | 25664854 |
Fusion gene breakpoints across ANXA1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across U2SURP (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChiTaRS5.0 | N/A | CB132862 | ANXA1 | chr9 | 75775236 | + | U2SURP | chr3 | 142769845 | + |
Top |
Fusion Gene ORF analysis for ANXA1-U2SURP |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000257497 | ENST00000397933 | ANXA1 | chr9 | 75775236 | + | U2SURP | chr3 | 142769845 | + |
In-frame | ENST00000257497 | ENST00000473835 | ANXA1 | chr9 | 75775236 | + | U2SURP | chr3 | 142769845 | + |
In-frame | ENST00000257497 | ENST00000493598 | ANXA1 | chr9 | 75775236 | + | U2SURP | chr3 | 142769845 | + |
In-frame | ENST00000376911 | ENST00000397933 | ANXA1 | chr9 | 75775236 | + | U2SURP | chr3 | 142769845 | + |
In-frame | ENST00000376911 | ENST00000473835 | ANXA1 | chr9 | 75775236 | + | U2SURP | chr3 | 142769845 | + |
In-frame | ENST00000376911 | ENST00000493598 | ANXA1 | chr9 | 75775236 | + | U2SURP | chr3 | 142769845 | + |
intron-3CDS | ENST00000491192 | ENST00000397933 | ANXA1 | chr9 | 75775236 | + | U2SURP | chr3 | 142769845 | + |
intron-3CDS | ENST00000491192 | ENST00000473835 | ANXA1 | chr9 | 75775236 | + | U2SURP | chr3 | 142769845 | + |
intron-3CDS | ENST00000491192 | ENST00000493598 | ANXA1 | chr9 | 75775236 | + | U2SURP | chr3 | 142769845 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000257497 | ANXA1 | chr9 | 75775236 | + | ENST00000397933 | U2SURP | chr3 | 142769845 | + | 5264 | 508 | 611 | 988 | 125 |
ENST00000257497 | ANXA1 | chr9 | 75775236 | + | ENST00000473835 | U2SURP | chr3 | 142769845 | + | 5085 | 508 | 806 | 420 | 128 |
ENST00000257497 | ANXA1 | chr9 | 75775236 | + | ENST00000493598 | U2SURP | chr3 | 142769845 | + | 1385 | 508 | 611 | 988 | 125 |
ENST00000376911 | ANXA1 | chr9 | 75775236 | + | ENST00000397933 | U2SURP | chr3 | 142769845 | + | 5964 | 1208 | 1506 | 1120 | 128 |
ENST00000376911 | ANXA1 | chr9 | 75775236 | + | ENST00000473835 | U2SURP | chr3 | 142769845 | + | 5785 | 1208 | 1506 | 1120 | 128 |
ENST00000376911 | ANXA1 | chr9 | 75775236 | + | ENST00000493598 | U2SURP | chr3 | 142769845 | + | 2085 | 1208 | 1506 | 1120 | 128 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000257497 | ENST00000397933 | ANXA1 | chr9 | 75775236 | + | U2SURP | chr3 | 142769845 | + | 0.20688201 | 0.79311794 |
ENST00000257497 | ENST00000473835 | ANXA1 | chr9 | 75775236 | + | U2SURP | chr3 | 142769845 | + | 0.10740478 | 0.89259523 |
ENST00000257497 | ENST00000493598 | ANXA1 | chr9 | 75775236 | + | U2SURP | chr3 | 142769845 | + | 0.12872308 | 0.8712769 |
ENST00000376911 | ENST00000397933 | ANXA1 | chr9 | 75775236 | + | U2SURP | chr3 | 142769845 | + | 0.1937122 | 0.80628777 |
ENST00000376911 | ENST00000473835 | ANXA1 | chr9 | 75775236 | + | U2SURP | chr3 | 142769845 | + | 0.09852127 | 0.9014787 |
ENST00000376911 | ENST00000493598 | ANXA1 | chr9 | 75775236 | + | U2SURP | chr3 | 142769845 | + | 0.13397202 | 0.866028 |
Top |
Fusion Genomic Features for ANXA1-U2SURP |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for ANXA1-U2SURP |
Go to FGviewer for the breakpoints of chr9:75775236-chr3:142769845 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
ANXA1 | . |
FUNCTION: Plays important roles in the innate immune response as effector of glucocorticoid-mediated responses and regulator of the inflammatory process. Has anti-inflammatory activity (PubMed:8425544). Plays a role in glucocorticoid-mediated down-regulation of the early phase of the inflammatory response (By similarity). Promotes resolution of inflammation and wound healing (PubMed:25664854). Functions at least in part by activating the formyl peptide receptors and downstream signaling cascades (PubMed:15187149, PubMed:25664854). Promotes chemotaxis of granulocytes and monocytes via activation of the formyl peptide receptors (PubMed:15187149). Contributes to the adaptive immune response by enhancing signaling cascades that are triggered by T-cell activation, regulates differentiation and proliferation of activated T-cells (PubMed:17008549). Promotes the differentiation of T-cells into Th1 cells and negatively regulates differentiation into Th2 cells (PubMed:17008549). Has no effect on unstimulated T cells (PubMed:17008549). Promotes rearrangement of the actin cytoskeleton, cell polarization and cell migration (PubMed:15187149). Negatively regulates hormone exocytosis via activation of the formyl peptide receptors and reorganization of the actin cytoskeleton (PubMed:19625660). Has high affinity for Ca(2+) and can bind up to eight Ca(2+) ions (By similarity). Displays Ca(2+)-dependent binding to phospholipid membranes (PubMed:2532504, PubMed:8557678). Plays a role in the formation of phagocytic cups and phagosomes. Plays a role in phagocytosis by mediating the Ca(2+)-dependent interaction between phagosomes and the actin cytoskeleton (By similarity). {ECO:0000250|UniProtKB:P10107, ECO:0000250|UniProtKB:P19619, ECO:0000269|PubMed:15187149, ECO:0000269|PubMed:17008549, ECO:0000269|PubMed:19625660, ECO:0000269|PubMed:2532504, ECO:0000269|PubMed:25664854, ECO:0000269|PubMed:2936963, ECO:0000269|PubMed:8425544, ECO:0000269|PubMed:8557678}. | FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | U2SURP | chr9:75775236 | chr3:142769845 | ENST00000397933 | 0 | 27 | 192_232 | 0 | 621.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | U2SURP | chr9:75775236 | chr3:142769845 | ENST00000397933 | 0 | 27 | 837_915 | 0 | 621.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | U2SURP | chr9:75775236 | chr3:142769845 | ENST00000397933 | 0 | 27 | 92_121 | 0 | 621.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | U2SURP | chr9:75775236 | chr3:142769845 | ENST00000473835 | 0 | 28 | 192_232 | 0 | 1030.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | U2SURP | chr9:75775236 | chr3:142769845 | ENST00000473835 | 0 | 28 | 837_915 | 0 | 1030.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | U2SURP | chr9:75775236 | chr3:142769845 | ENST00000473835 | 0 | 28 | 92_121 | 0 | 1030.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | U2SURP | chr9:75775236 | chr3:142769845 | ENST00000397933 | 0 | 27 | 357_402 | 0 | 621.0 | Compositional bias | Note=Pro-rich | |
Tgene | U2SURP | chr9:75775236 | chr3:142769845 | ENST00000397933 | 0 | 27 | 689_746 | 0 | 621.0 | Compositional bias | Note=Asp-rich | |
Tgene | U2SURP | chr9:75775236 | chr3:142769845 | ENST00000397933 | 0 | 27 | 762_917 | 0 | 621.0 | Compositional bias | Note=Glu-rich | |
Tgene | U2SURP | chr9:75775236 | chr3:142769845 | ENST00000397933 | 0 | 27 | 922_1001 | 0 | 621.0 | Compositional bias | Note=Arg/Ser-rich | |
Tgene | U2SURP | chr9:75775236 | chr3:142769845 | ENST00000473835 | 0 | 28 | 357_402 | 0 | 1030.0 | Compositional bias | Note=Pro-rich | |
Tgene | U2SURP | chr9:75775236 | chr3:142769845 | ENST00000473835 | 0 | 28 | 689_746 | 0 | 1030.0 | Compositional bias | Note=Asp-rich | |
Tgene | U2SURP | chr9:75775236 | chr3:142769845 | ENST00000473835 | 0 | 28 | 762_917 | 0 | 1030.0 | Compositional bias | Note=Glu-rich | |
Tgene | U2SURP | chr9:75775236 | chr3:142769845 | ENST00000473835 | 0 | 28 | 922_1001 | 0 | 1030.0 | Compositional bias | Note=Arg/Ser-rich | |
Tgene | U2SURP | chr9:75775236 | chr3:142769845 | ENST00000397933 | 0 | 27 | 274_355 | 0 | 621.0 | Domain | RRM | |
Tgene | U2SURP | chr9:75775236 | chr3:142769845 | ENST00000397933 | 0 | 27 | 534_679 | 0 | 621.0 | Domain | CID | |
Tgene | U2SURP | chr9:75775236 | chr3:142769845 | ENST00000473835 | 0 | 28 | 274_355 | 0 | 1030.0 | Domain | RRM | |
Tgene | U2SURP | chr9:75775236 | chr3:142769845 | ENST00000473835 | 0 | 28 | 534_679 | 0 | 1030.0 | Domain | CID | |
Tgene | U2SURP | chr9:75775236 | chr3:142769845 | ENST00000397933 | 0 | 27 | 430_473 | 0 | 621.0 | Repeat | Note=SURP motif | |
Tgene | U2SURP | chr9:75775236 | chr3:142769845 | ENST00000473835 | 0 | 28 | 430_473 | 0 | 1030.0 | Repeat | Note=SURP motif |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | ANXA1 | chr9:75775236 | chr3:142769845 | ENST00000257497 | + | 1 | 13 | 114_185 | 0 | 347.0 | Repeat | Annexin 2 |
Hgene | ANXA1 | chr9:75775236 | chr3:142769845 | ENST00000257497 | + | 1 | 13 | 197_269 | 0 | 347.0 | Repeat | Annexin 3 |
Hgene | ANXA1 | chr9:75775236 | chr3:142769845 | ENST00000257497 | + | 1 | 13 | 273_344 | 0 | 347.0 | Repeat | Annexin 4 |
Hgene | ANXA1 | chr9:75775236 | chr3:142769845 | ENST00000257497 | + | 1 | 13 | 42_113 | 0 | 347.0 | Repeat | Annexin 1 |
Hgene | ANXA1 | chr9:75775236 | chr3:142769845 | ENST00000376911 | + | 1 | 12 | 114_185 | 0 | 347.0 | Repeat | Annexin 2 |
Hgene | ANXA1 | chr9:75775236 | chr3:142769845 | ENST00000376911 | + | 1 | 12 | 197_269 | 0 | 347.0 | Repeat | Annexin 3 |
Hgene | ANXA1 | chr9:75775236 | chr3:142769845 | ENST00000376911 | + | 1 | 12 | 273_344 | 0 | 347.0 | Repeat | Annexin 4 |
Hgene | ANXA1 | chr9:75775236 | chr3:142769845 | ENST00000376911 | + | 1 | 12 | 42_113 | 0 | 347.0 | Repeat | Annexin 1 |
Top |
Fusion Gene Sequence for ANXA1-U2SURP |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000257497_ENST00000397933_CB132862_ANXA1_chr9_75775236_+_U2SURP_chr3_142769845_length(transcript)=5264nt_BP=508nt AGCTGAGCCATGTACTTCAAACAGAAGGCAGCCAATTACTAACTTCTGGTTGCTAGGTGTGGCTTCCTTTAAAATCCTATAAAATCAGAA GCCCAAGTCTCCACTGCCAGTGTGAAATCTTCAGAGAAGAATTTCTCTTTAGTTCTTTGCAAGAAGGTAGAGATAAAGACACTTTTTCAA AAATGGCAATGGTATCAGAATTCCTCAAGCAGGCCTGGTTTATTGAAAATGAAGAGCAGGAATATGTTCAAACTGTGAAGTCATCCAAAG GTGGTCCCGGATCAGCGGTGAGCCCCTATCCTACCTTCAATCCATCCTCGGATGTCGCTGCCTTGCATAAGGCCATAATGGTTAAAGGTG TGGATGAAGCAACCATCATTGACATTCTAACTAAGCGAAACAATGCACAGCGTCAACAGATCAAAGCAGCATATCTCCAGGAAACAGGAA AGCTCTGCTAAAAACTCCAGCGCAATTTGATGCTGATGAACTTCGTGCTGCCATGAAGTTTTCAGGAGCAAGTAGAACACTACAGAGATA AACTTCTTCAACGAGAGAAAGAGAAAGAGTTAGAAAGAGAACGAGAAAGAGACAAGAAAGATAAAGAAAAATTGGAATCTCGCTCCAAAG ACAAGAAGGAAAAAGATGAGTGTACTCCGACAAGGAAGGAAAGGAAGAGGCGACACAGTACATCCCCCAGCCCATCTCGCAGTAGCAGTG GTAGACGAGTGAAATCCCCATCACCAAAATCGGAGCGATCAGAGCGTTCAGAAAGATCTCATAAAGAGAGCTCACGGTCCAGGTCATCTC ACAAAGATTCTCCTAGAGATGTTAGCAAAAAAGCCAAAAGATCACCATCTGGTTCAAGGACACCTAAAAGGTCTAGGCGATCACGGTCTA GATCTCCTAAAAAATCAGGAAAGAAGTCCAGATCCCAGTCCAGATCTCCACACAGGTCTCATAAAAAGTCAAAGAAAAACAAACACTGAC GTAAATTTTTAAGATGCTGTCACTTATTGGAAATGCGATTTGTTTTGTGCCTGAACGGTCTGTTTTTTAAAAAAACAAAAAATCAAATGA AAGAGCATTCCTGGGGTTTTTTGTTTGTTTGTGTATGCATGTGTAAACTCATGAGCAACTGCATCTGTAGATCTGTCATTGTTTTATATT GTGTAAATTACTTTCATTGTGGCTATTTCTCAAGATGAAATTTTTATTGTTCTAATGGATTTCATCAGAAATGTGTATAATGGATCTGCT GACAGTAGTAGTATTTTGTTTTAGGATGTTGTGACTTAGCAAAAATAATACAGATGTCTTCCCCCCTTTTGTAGCTTTGACAATTTGAAT TAGATTTCAAATAAAATCTGAACAGAAAACTATAATGTTGTTTTTTTGCCCCACCGGTGATATTAAGTCCCTTAAAGTCCTACTGAGTTT CACACTACTGTTGTGCTTCTTATACCTGATGCACTTTATAAGCCCCAGTGTTCAAGTAGCTTAAGTTTTATATTTACTAAGATGACTATC CAAATTAAGGGACCTGAGACTCCTATTTGGTGGTTTGCTAACCATTTGCTTTTGATAAGTTTCTCTTGGGTAATACTAATACCCAGATAT CAAAGACTAGGTAGATATGGCATGGCGTTTTGTTAGTGGAATGCCTGGCTAAAACATTTTTTTCACAGAAGCAATATGATTTCCATACAT CCAACCCATGTTCTGAGCAACTACTTACTTTTAGGGGGAAATTAAATATCTTTTCATTTCCTCTTCTATTATGAAAGAAGTTTATTTGTA AAACAAATTTTCTAACAAGGTTTGGCCATAGAATTCTCTTGTATGATCGTTGACCTTTTATAATCTTCTGTAGGCTATCTTTCAAACACT GGCATCAGAATATTTTTTATAAGTTTGTGTTTAAACAGCTTAGTTGGTCCCCCCCCACTCCCAAGAGACTTGGGTTTAGTTATAGCTTTA AGTAAAATTTAAAAATAAAATGTTTTTCAGGAAACTTCGTATCTAATGGTTTGTAAATTCAAGGTGCAAAAAGTTGATTTAAACCATTTG CAGAGTTGAACTCTATTATGAAAATAAATTTGCTACGGTATGAGGAAGAAATAAAACTTGTGTAATGTTGGTCATAATACTGCTATAAAT ATAATAAAGGGTTATGTAGAATTGAACTGACACTATTATTTGTGAATCTTGATTTCAGTTTTTTATGTAGGCACTTCATACACTGGTTTG ATGGGTTTTTTTTTTCCTCCCTAAAAGAGAAAGTAGAAAACTATTCTAACAATGGATTATTTTGATTTAGCTTGCTTTTTAAAAAAATCT TTTCAACTTGTTTTACTTAATCTTGCCTAGTCACAAAATAAGATGTGCACCCATGGTTTGGAGAGTTCCTATATTAGCTGAGCAGTGAGA TACACTATTTCCAAACGGTGCACACCTACAGTAGCTTTGGAAATGAGCCAATCACTGTTTTACTTAATGGTTCTTATCAGCATGCAAATA TTGCTTGAAAGTTATTTCCTTATTCACTGTTTTGTTAGTCCATTTTGTTAGGAAACATTAATTCCTAAAAATTTGTTCAGAATAATTAAA AGTGAACATTTGGTGCTGATACTCAAAAACCTACAAATGTAGCCATTTAAAAAGTAACATGTTTTTCTCCCCTGCTCATTGCCTGGGAGA ATGGAATTTTATATAACTACCTTTCTTTGCAAAAATAACGGTCGTGTCGAGTTGGTGGTGATTTTGGCATTCCATCTTGCACTGGTTTCT AGTATAGGCTTAGAAATAATTGGTCAGGTAATAATCTTTCCAGTCAAGTTGCAAGGGATGCTTATTTCTCTTCAAAAAAAGACATCCTGC GGGATTGAGTAGAAAATTTTAGGTCAGTTTTGGGTGCTTATTTGTAATATTTTTCCTACTACATTGGAGTTTAGCAGTTCTTTTTTTCTG GATCCAGATACAAGTGTCATGGTTTATCTTACAGTGGGTGAAACTGACTTTCTTTTGGTTGGGTGGGTGAGGATTTCTTAGGCCTGATAG AATATATATTCTGTGAAGTTTGTTAATGTACATATTAGATTGTATTGGATTTTTTTTTCTTGAATTGCAAATGGTATTATTAGATAGGTT ATTTCCAGTTTTACTTCATGACAAATTACCTAGAGTAAACCTACTTAATACTCCCATGGATTCTATGAAAGTTTAATGGGATCAGAAATT GGTGACTTATAAGGGGGAAGATATTCTACCATATTTTTATAATAGCTTATTATTCATGTTTCTTGTCTGAAGGACACTCAAGTTACAGAG CAAAATTTCTATAGGTTGACTAGAATGTTCATAAGCATGGTCTTCCAGTTGCAGGAAAGATCATGTTCTATCTGTGGACACTTACTGTCC TCTACCACAGCTACGTGCCAGAGTTGTTTTCCACAGTTCTTATAAAGGGCATGACTTAGGCTCTTTACCCTCCAACTTAATGTTTATACA CAGGGATTGTTTACTAGGTTAATGACATTTAACTCCCCTCTCTTCTGTAGGTGAGAGAAAATAAGTAAGTCTTGATCTGTTTCTTACCAA AGAGAGACAGACCTATGATGGAAAATGATCACGTCTCTGAATTTTTTCTTTAACGTTATAGTTCCTTATTACAGATAGTAAGCATATGGG AATTTCTGAGCTATAACATGTTGAGAAGTTAGAAATTAAAACTAACACAACAAAAGGCGCTGAATCAAAAGATCTTTGCTTTTATTTGGC TCAGAATGTTTTTGGCTTTTCTGCTAAAGATGGCAGAAATTACTCTACACAGACCTGATTTTTCTTTATTGCAGACCATTCTTGTGGGCT TACCCTGAGACTTTTATCCCAATTAGTGAATCTTGGAGGGAATACTTGCTTATTTATGACTTAGGTATTTCCCCCCAAACTTTAATATTC TTGAGCACTTGAAAATACTTTTGAGAAATTTTAACTGTGATTAAATTTAGGTTTATTAGAAATATTCTGTACACATTTGCCTCCATGGTG GCGTAAGTTCTGAAAAATTATATGACCGTGACAATAGTTTATCATCATCATTATTGTTATTCAAAATAAGGGTAAATAAATCTCTGTATT GCCAAAGTGACTTAAACTGTTCTGATGACCACACAGTGTGATTTCTTTAGCAGAGAAAGTTGGTTTTAAAAATAAATAGTACCACTTTTC TAAGACTGTACAGTTTACAAATAAGGTTTTTTTCTTTGTTGTTTTCCTCTTCTATTAAGTTTTAGTGAAAAGCCTAATTACAGAAAATTG TGCAGATACTAGTGAAGATACTAGTATAAGTTTAAAGGAACACGTGACTGTAAAATCTCACATTTACAAAGTGCTTGATCTCTTCATATT TCACACGCATGTTTTAGAATAGATTTTAGGGAGTGTTTAATTCATTATCCTTTTGACTTAAAATTTTTGTTACCAACTTCCTAGGACTTA GATAATATATAAATAAGTACAAATCCCAGGGGAAGTGTTGTGATGCTAGACTAAAAGGTGGGAATGTGCTGCTGTTCCGTGAGCCTTGTT CCATTGTTGAAAATTTGATGCCTCAGTGTTTATTCAGTACCACCTCATGGAGCTTCAATGTAAATGGATTATATGTATAATTGGTAATTT GTATAGTTTTGTAGATTGTAGATTAAATGCACTCATCATGTCACATGTAATTGTGCTTGGAGTATTTGTGTTTTATTCTTTTACTTCAAC GGGTTCTTGTCTGTTACATCTCTGGTGATTTGAAATATCAGGAAAGACAGTTTGTCAGAAATGAGAATAATATAGTTGAAATCAGTTGGG CTAAAATATTCTACAGCAAGACAATTTCTTTTGGGTGAACTGATTCTATAATTTACTTACTTTTAATGTAAGGATTAGATTTATTGTTGA GCTGCTTTCCAGATCAGACTGTCACTTTATAGTTTTTCTACATAAAGATTATATAGTTGCAAACAAAGGTTGTGAAATTTCCCTTTTGTT GTTTTTGACTTTTAATTAATAAAAGTACATTGTTTTCATAGCAAACTTAGACTGTCCATGTAATTTTCTCCATATTGTTTTTCCGATGCA AGCCCAGTTAATAATTAGTTTTTTAGCAGCTTTCTCTCAAGTGAAATAAGTGATGTGACATGTTTATCAGTTATGGCTAAAATGTTACAC >In-frame_ENST00000257497_ENST00000397933_CB132862_ANXA1_chr9_75775236_+_U2SURP_chr3_142769845_length(amino acids)=125AA_start in transcript=611_stop in transcript=988 MESRSKDKKEKDECTPTRKERKRRHSTSPSPSRSSSGRRVKSPSPKSERSERSERSHKESSRSRSSHKDSPRDVSKKAKRSPSGSRTPKR -------------------------------------------------------------- >In-frame_ENST00000257497_ENST00000473835_CB132862_ANXA1_chr9_75775236_+_U2SURP_chr3_142769845_length(transcript)=5085nt_BP=508nt AGCTGAGCCATGTACTTCAAACAGAAGGCAGCCAATTACTAACTTCTGGTTGCTAGGTGTGGCTTCCTTTAAAATCCTATAAAATCAGAA GCCCAAGTCTCCACTGCCAGTGTGAAATCTTCAGAGAAGAATTTCTCTTTAGTTCTTTGCAAGAAGGTAGAGATAAAGACACTTTTTCAA AAATGGCAATGGTATCAGAATTCCTCAAGCAGGCCTGGTTTATTGAAAATGAAGAGCAGGAATATGTTCAAACTGTGAAGTCATCCAAAG GTGGTCCCGGATCAGCGGTGAGCCCCTATCCTACCTTCAATCCATCCTCGGATGTCGCTGCCTTGCATAAGGCCATAATGGTTAAAGGTG TGGATGAAGCAACCATCATTGACATTCTAACTAAGCGAAACAATGCACAGCGTCAACAGATCAAAGCAGCATATCTCCAGGAAACAGGAA AGCTCTGCTAAAAACTCCAGCGCAATTTGATGCTGATGAACTTCGTGCTGCCATGAAGTTTTCAGGAGCAAGTAGAACACTACAGAGATA AACTTCTTCAACGAGAGAAAGAGAAAGAGTTAGAAAGAGAACGAGAAAGAGACAAGAAAGATAAAGAAAAATTGGAATCTCGCTCCAAAG ACAAGAAGGAAAAAGATGAGTGTACTCCGACAAGGAAGGAAAGGAAGAGGCGACACAGTACATCCCCCAGCCCATCTCGCAGTAGCAGTG GTAGACGAGTGAAATCCCCATCACCAAAATCGGAGCGATCAGAGCGTTCAGAAAGATCTCATAAAGAGAGCTCACGGTCCAGGTCATCTC ACAAAGATTCTCCTAGAGATGTTAGCAAAAAAGCCAAAAGATCACCATCTGGTTCAAGGACACCTAAAAGGTCTAGGCGATCACGGTCTA GATCTCCTAAAAAATCAGGAAAGAAGTCCAGATCCCAGTCCAGATCTCCACACAGGTCTCATAAAAAGTCAAAGAAAAACAAACACTGAC GTAAATTTTTAAGATGCTGTCACTTATTGGAAATGCGATTTGTTTTGTGCCTGAACGGTCTGTTTTTTAAAAAAACAAAAAATCAAATGA AAGAGCATTCCTGGGGTTTTTTGTTTGTTTGTGTATGCATGTGTAAACTCATGAGCAACTGCATCTGTAGATCTGTCATTGTTTTATATT GTGTAAATTACTTTCATTGTGGCTATTTCTCAAGATGAAATTTTTATTGTTCTAATGGATTTCATCAGAAATGTGTATAATGGATCTGCT GACAGTAGTAGTATTTTGTTTTAGGATGTTGTGACTTAGCAAAAATAATACAGATGTCTTCCCCCCTTTTGTAGCTTTGACAATTTGAAT TAGATTTCAAATAAAATCTGAACAGAAAACTATAATGTTGTTTTTTTGCCCCACCGGTGATATTAAGTCCCTTAAAGTCCTACTGAGTTT CACACTACTGTTGTGCTTCTTATACCTGATGCACTTTATAAGCCCCAGTGTTCAAGTAGCTTAAGTTTTATATTTACTAAGATGACTATC CAAATTAAGGGACCTGAGACTCCTATTTGGTGGTTTGCTAACCATTTGCTTTTGATAAGTTTCTCTTGGGTAATACTAATACCCAGATAT CAAAGACTAGGTAGATATGGCATGGCGTTTTGTTAGTGGAATGCCTGGCTAAAACATTTTTTTCACAGAAGCAATATGATTTCCATACAT CCAACCCATGTTCTGAGCAACTACTTACTTTTAGGGGGAAATTAAATATCTTTTCATTTCCTCTTCTATTATGAAAGAAGTTTATTTGTA AAACAAATTTTCTAACAAGGTTTGGCCATAGAATTCTCTTGTATGATCGTTGACCTTTTATAATCTTCTGTAGGCTATCTTTCAAACACT GGCATCAGAATATTTTTTATAAGTTTGTGTTTAAACAGCTTAGTTGGTCCCCCCCCACTCCCAAGAGACTTGGGTTTAGTTATAGCTTTA AGTAAAATTTAAAAATAAAATGTTTTTCAGGAAACTTCGTATCTAATGGTTTGTAAATTCAAGGTGCAAAAAGTTGATTTAAACCATTTG CAGAGTTGAACTCTATTATGAAAATAAATTTGCTACGGTATGAGGAAGAAATAAAACTTGTGTAATGTTGGTCATAATACTGCTATAAAT ATAATAAAGGGTTATGTAGAATTGAACTGACACTATTATTTGTGAATCTTGATTTCAGTTTTTTATGTAGGCACTTCATACACTGGTTTG ATGGGTTTTTTTTTTCCTCCCTAAAAGAGAAAGTAGAAAACTATTCTAACAATGGATTATTTTGATTTAGCTTGCTTTTTAAAAAAATCT TTTCAACTTGTTTTACTTAATCTTGCCTAGTCACAAAATAAGATGTGCACCCATGGTTTGGAGAGTTCCTATATTAGCTGAGCAGTGAGA TACACTATTTCCAAACGGTGCACACCTACAGTAGCTTTGGAAATGAGCCAATCACTGTTTTACTTAATGGTTCTTATCAGCATGCAAATA TTGCTTGAAAGTTATTTCCTTATTCACTGTTTTGTTAGTCCATTTTGTTAGGAAACATTAATTCCTAAAAATTTGTTCAGAATAATTAAA AGTGAACATTTGGTGCTGATACTCAAAAACCTACAAATGTAGCCATTTAAAAAGTAACATGTTTTTCTCCCCTGCTCATTGCCTGGGAGA ATGGAATTTTATATAACTACCTTTCTTTGCAAAAATAACGGTCGTGTCGAGTTGGTGGTGATTTTGGCATTCCATCTTGCACTGGTTTCT AGTATAGGCTTAGAAATAATTGGTCAGGTAATAATCTTTCCAGTCAAGTTGCAAGGGATGCTTATTTCTCTTCAAAAAAAGACATCCTGC GGGATTGAGTAGAAAATTTTAGGTCAGTTTTGGGTGCTTATTTGTAATATTTTTCCTACTACATTGGAGTTTAGCAGTTCTTTTTTTCTG GATCCAGATACAAGTGTCATGGTTTATCTTACAGTGGGTGAAACTGACTTTCTTTTGGTTGGGTGGGTGAGGATTTCTTAGGCCTGATAG AATATATATTCTGTGAAGTTTGTTAATGTACATATTAGATTGTATTGGATTTTTTTTTCTTGAATTGCAAATGGTATTATTAGATAGGTT ATTTCCAGTTTTACTTCATGACAAATTACCTAGAGTAAACCTACTTAATACTCCCATGGATTCTATGAAAGTTTAATGGGATCAGAAATT GGTGACTTATAAGGGGGAAGATATTCTACCATATTTTTATAATAGCTTATTATTCATGTTTCTTGTCTGAAGGACACTCAAGTTACAGAG CAAAATTTCTATAGGTTGACTAGAATGTTCATAAGCATGGTCTTCCAGTTGCAGGAAAGATCATGTTCTATCTGTGGACACTTACTGTCC TCTACCACAGCTACGTGCCAGAGTTGTTTTCCACAGTTCTTATAAAGGGCATGACTTAGGCTCTTTACCCTCCAACTTAATGTTTATACA CAGGGATTGTTTACTAGGTTAATGACATTTAACTCCCCTCTCTTCTGTAGGTGAGAGAAAATAAGTAAGTCTTGATCTGTTTCTTACCAA AGAGAGACAGACCTATGATGGAAAATGATCACGTCTCTGAATTTTTTCTTTAACGTTATAGTTCCTTATTACAGATAGTAAGCATATGGG AATTTCTGAGCTATAACATGTTGAGAAGTTAGAAATTAAAACTAACACAACAAAAGGCGCTGAATCAAAAGATCTTTGCTTTTATTTGGC TCAGAATGTTTTTGGCTTTTCTGCTAAAGATGGCAGAAATTACTCTACACAGACCTGATTTTTCTTTATTGCAGACCATTCTTGTGGGCT TACCCTGAGACTTTTATCCCAATTAGTGAATCTTGGAGGGAATACTTGCTTATTTATGACTTAGGTATTTCCCCCCAAACTTTAATATTC TTGAGCACTTGAAAATACTTTTGAGAAATTTTAACTGTGATTAAATTTAGGTTTATTAGAAATATTCTGTACACATTTGCCTCCATGGTG GCGTAAGTTCTGAAAAATTATATGACCGTGACAATAGTTTATCATCATCATTATTGTTATTCAAAATAAGGGTAAATAAATCTCTGTATT GCCAAAGTGACTTAAACTGTTCTGATGACCACACAGTGTGATTTCTTTAGCAGAGAAAGTTGGTTTTAAAAATAAATAGTACCACTTTTC TAAGACTGTACAGTTTACAAATAAGGTTTTTTTCTTTGTTGTTTTCCTCTTCTATTAAGTTTTAGTGAAAAGCCTAATTACAGAAAATTG TGCAGATACTAGTGAAGATACTAGTATAAGTTTAAAGGAACACGTGACTGTAAAATCTCACATTTACAAAGTGCTTGATCTCTTCATATT TCACACGCATGTTTTAGAATAGATTTTAGGGAGTGTTTAATTCATTATCCTTTTGACTTAAAATTTTTGTTACCAACTTCCTAGGACTTA GATAATATATAAATAAGTACAAATCCCAGGGGAAGTGTTGTGATGCTAGACTAAAAGGTGGGAATGTGCTGCTGTTCCGTGAGCCTTGTT CCATTGTTGAAAATTTGATGCCTCAGTGTTTATTCAGTACCACCTCATGGAGCTTCAATGTAAATGGATTATATGTATAATTGGTAATTT GTATAGTTTTGTAGATTGTAGATTAAATGCACTCATCATGTCACATGTAATTGTGCTTGGAGTATTTGTGTTTTATTCTTTTACTTCAAC GGGTTCTTGTCTGTTACATCTCTGGTGATTTGAAATATCAGGAAAGACAGTTTGTCAGAAATGAGAATAATATAGTTGAAATCAGTTGGG CTAAAATATTCTACAGCAAGACAATTTCTTTTGGGTGAACTGATTCTATAATTTACTTACTTTTAATGTAAGGATTAGATTTATTGTTGA GCTGCTTTCCAGATCAGACTGTCACTTTATAGTTTTTCTACATAAAGATTATATAGTTGCAAACAAAGGTTGTGAAATTTCCCTTTTGTT >In-frame_ENST00000257497_ENST00000473835_CB132862_ANXA1_chr9_75775236_+_U2SURP_chr3_142769845_length(amino acids)=128AA_start in transcript=806_stop in transcript=420 MTWTVSSLYEIFLNALIAPILVMGISLVYHCYCEMGWGMYCVASSFPSLSEYTHLFPSCLWSEIPIFLYLSCLFLVLFLTLSLSLVEEVY -------------------------------------------------------------- >In-frame_ENST00000257497_ENST00000493598_CB132862_ANXA1_chr9_75775236_+_U2SURP_chr3_142769845_length(transcript)=1385nt_BP=508nt AGCTGAGCCATGTACTTCAAACAGAAGGCAGCCAATTACTAACTTCTGGTTGCTAGGTGTGGCTTCCTTTAAAATCCTATAAAATCAGAA GCCCAAGTCTCCACTGCCAGTGTGAAATCTTCAGAGAAGAATTTCTCTTTAGTTCTTTGCAAGAAGGTAGAGATAAAGACACTTTTTCAA AAATGGCAATGGTATCAGAATTCCTCAAGCAGGCCTGGTTTATTGAAAATGAAGAGCAGGAATATGTTCAAACTGTGAAGTCATCCAAAG GTGGTCCCGGATCAGCGGTGAGCCCCTATCCTACCTTCAATCCATCCTCGGATGTCGCTGCCTTGCATAAGGCCATAATGGTTAAAGGTG TGGATGAAGCAACCATCATTGACATTCTAACTAAGCGAAACAATGCACAGCGTCAACAGATCAAAGCAGCATATCTCCAGGAAACAGGAA AGCTCTGCTAAAAACTCCAGCGCAATTTGATGCTGATGAACTTCGTGCTGCCATGAAGTTTTCAGGAGCAAGTAGAACACTACAGAGATA AACTTCTTCAACGAGAGAAAGAGAAAGAGTTAGAAAGAGAACGAGAAAGAGACAAGAAAGATAAAGAAAAATTGGAATCTCGCTCCAAAG ACAAGAAGGAAAAAGATGAGTGTACTCCGACAAGGAAGGAAAGGAAGAGGCGACACAGTACATCCCCCAGCCCATCTCGCAGTAGCAGTG GTAGACGAGTGAAATCCCCATCACCAAAATCGGAGCGATCAGAGCGTTCAGAAAGATCTCATAAAGAGAGCTCACGGTCCAGGTCATCTC ACAAAGATTCTCCTAGAGATGTTAGCAAAAAAGCCAAAAGATCACCATCTGGTTCAAGGACACCTAAAAGGTCTAGGCGATCACGGTCTA GATCTCCTAAAAAATCAGGAAAGAAGTCCAGATCCCAGTCCAGATCTCCACACAGGTCTCATAAAAAGTCAAAGAAAAACAAACACTGAC GTAAATTTTTAAGATGCTGTCACTTATTGGAAATGCGATTTGTTTTGTGCCTGAACGGTCTGTTTTTTAAAAAAACAAAAAATCAAATGA AAGAGCATTCCTGGGGTTTTTTGTTTGTTTGTGTATGCATGTGTAAACTCATGAGCAACTGCATCTGTAGATCTGTCATTGTTTTATATT GTGTAAATTACTTTCATTGTGGCTATTTCTCAAGATGAAATTTTTATTGTTCTAATGGATTTCATCAGAAATGTGTATAATGGATCTGCT GACAGTAGTAGTATTTTGTTTTAGGATGTTGTGACTTAGCAAAAATAATACAGATGTCTTCCCCCCTTTTGTAGCTTTGACAATTTGAAT >In-frame_ENST00000257497_ENST00000493598_CB132862_ANXA1_chr9_75775236_+_U2SURP_chr3_142769845_length(amino acids)=125AA_start in transcript=611_stop in transcript=988 MESRSKDKKEKDECTPTRKERKRRHSTSPSPSRSSSGRRVKSPSPKSERSERSERSHKESSRSRSSHKDSPRDVSKKAKRSPSGSRTPKR -------------------------------------------------------------- >In-frame_ENST00000376911_ENST00000397933_CB132862_ANXA1_chr9_75775236_+_U2SURP_chr3_142769845_length(transcript)=5964nt_BP=1208nt AAAAAAAAAAAAAAAAAAAAAAGCAATCATTAAGCTTTTCATCTAGCCATTACTTTTGTACAGGCTCTCATTAATTCCACATAGATGGTC TAATGGTCTACTAAATAGTATTCTAATCCTCCATCTTGTCTATCTCTTAGCCATTCTCCATGATAAAGGATGAATGGTCTTTCGGAAACA TAAATGAAACCATGCTGCTTTAAAAAAACAAACAAACAAAAAGAAACCCATTAATGTTTTCCCAAAGCTTTGTGGACACATTGAAGCTTC TTGTTTCAGCTTCTGCCAACATTTCTCGCTCCAGCAAACTTTCTTCTGCTTCCCAAATATGACAAGCTTCTTCTTTAACTTTTCTGCCAG GTTAATCTTGACTCATTTCAAGAGAGGCTTGGGTCAGCCAGGGCCTACTCTAAGAAGTTTCTTTAGCCCTTATGTTTTCCTATGGAGAGC ACACACTAGCTTTAAGTCCTGAGGGTACTTAAGATGATATTTCAATGTTTTTGTACTCTTAGTGCTTGGCATATGGTGGGTGGTCTACAA ATTTAGAACAATGTAGTGAACCACAAACTCCTCTCTTCAGCCTGTGTGCTTACTTGTAGTAGTTGTCTGATCTCTAAAATTTAGAACTGA ATATGCCAAGAAAGAGTTCAATTTCAGAGAGGAGGGTATGGTTTCATTTTAAGTATAAAAGCTTCCTTTAAAAAAAATTACGTCTTACAT TTTGTTATGCTCCTAAGTGTAATTGATCCTGGAAAGTAAGCGCAAGGCTACTCTCTAATGCTAACTCTTATGTATGTAAGAGGTGAGGAA GGAGAGGTTGTGTGTGGTGCATTTGTTTTGTAAAAGCATCTAACTGTTTTCTTTCCAGACACTTTTTCAAAAATGGCAATGGTATCAGAA TTCCTCAAGCAGGCCTGGTTTATTGAAAATGAAGAGCAGGAATATGTTCAAACTGTGAAGTCATCCAAAGGTGGTCCCGGATCAGCGGTG AGCCCCTATCCTACCTTCAATCCATCCTCGGATGTCGCTGCCTTGCATAAGGCCATAATGGTTAAAGGTGTGGATGAAGCAACCATCATT GACATTCTAACTAAGCGAAACAATGCACAGCGTCAACAGATCAAAGCAGCATATCTCCAGGAAACAGGAAAGCTCTGCTAAAAACTCCAG CGCAATTTGATGCTGATGAACTTCGTGCTGCCATGAAGTTTTCAGGAGCAAGTAGAACACTACAGAGATAAACTTCTTCAACGAGAGAAA GAGAAAGAGTTAGAAAGAGAACGAGAAAGAGACAAGAAAGATAAAGAAAAATTGGAATCTCGCTCCAAAGACAAGAAGGAAAAAGATGAG TGTACTCCGACAAGGAAGGAAAGGAAGAGGCGACACAGTACATCCCCCAGCCCATCTCGCAGTAGCAGTGGTAGACGAGTGAAATCCCCA TCACCAAAATCGGAGCGATCAGAGCGTTCAGAAAGATCTCATAAAGAGAGCTCACGGTCCAGGTCATCTCACAAAGATTCTCCTAGAGAT GTTAGCAAAAAAGCCAAAAGATCACCATCTGGTTCAAGGACACCTAAAAGGTCTAGGCGATCACGGTCTAGATCTCCTAAAAAATCAGGA AAGAAGTCCAGATCCCAGTCCAGATCTCCACACAGGTCTCATAAAAAGTCAAAGAAAAACAAACACTGACGTAAATTTTTAAGATGCTGT CACTTATTGGAAATGCGATTTGTTTTGTGCCTGAACGGTCTGTTTTTTAAAAAAACAAAAAATCAAATGAAAGAGCATTCCTGGGGTTTT TTGTTTGTTTGTGTATGCATGTGTAAACTCATGAGCAACTGCATCTGTAGATCTGTCATTGTTTTATATTGTGTAAATTACTTTCATTGT GGCTATTTCTCAAGATGAAATTTTTATTGTTCTAATGGATTTCATCAGAAATGTGTATAATGGATCTGCTGACAGTAGTAGTATTTTGTT TTAGGATGTTGTGACTTAGCAAAAATAATACAGATGTCTTCCCCCCTTTTGTAGCTTTGACAATTTGAATTAGATTTCAAATAAAATCTG AACAGAAAACTATAATGTTGTTTTTTTGCCCCACCGGTGATATTAAGTCCCTTAAAGTCCTACTGAGTTTCACACTACTGTTGTGCTTCT TATACCTGATGCACTTTATAAGCCCCAGTGTTCAAGTAGCTTAAGTTTTATATTTACTAAGATGACTATCCAAATTAAGGGACCTGAGAC TCCTATTTGGTGGTTTGCTAACCATTTGCTTTTGATAAGTTTCTCTTGGGTAATACTAATACCCAGATATCAAAGACTAGGTAGATATGG CATGGCGTTTTGTTAGTGGAATGCCTGGCTAAAACATTTTTTTCACAGAAGCAATATGATTTCCATACATCCAACCCATGTTCTGAGCAA CTACTTACTTTTAGGGGGAAATTAAATATCTTTTCATTTCCTCTTCTATTATGAAAGAAGTTTATTTGTAAAACAAATTTTCTAACAAGG TTTGGCCATAGAATTCTCTTGTATGATCGTTGACCTTTTATAATCTTCTGTAGGCTATCTTTCAAACACTGGCATCAGAATATTTTTTAT AAGTTTGTGTTTAAACAGCTTAGTTGGTCCCCCCCCACTCCCAAGAGACTTGGGTTTAGTTATAGCTTTAAGTAAAATTTAAAAATAAAA TGTTTTTCAGGAAACTTCGTATCTAATGGTTTGTAAATTCAAGGTGCAAAAAGTTGATTTAAACCATTTGCAGAGTTGAACTCTATTATG AAAATAAATTTGCTACGGTATGAGGAAGAAATAAAACTTGTGTAATGTTGGTCATAATACTGCTATAAATATAATAAAGGGTTATGTAGA ATTGAACTGACACTATTATTTGTGAATCTTGATTTCAGTTTTTTATGTAGGCACTTCATACACTGGTTTGATGGGTTTTTTTTTTCCTCC CTAAAAGAGAAAGTAGAAAACTATTCTAACAATGGATTATTTTGATTTAGCTTGCTTTTTAAAAAAATCTTTTCAACTTGTTTTACTTAA TCTTGCCTAGTCACAAAATAAGATGTGCACCCATGGTTTGGAGAGTTCCTATATTAGCTGAGCAGTGAGATACACTATTTCCAAACGGTG CACACCTACAGTAGCTTTGGAAATGAGCCAATCACTGTTTTACTTAATGGTTCTTATCAGCATGCAAATATTGCTTGAAAGTTATTTCCT TATTCACTGTTTTGTTAGTCCATTTTGTTAGGAAACATTAATTCCTAAAAATTTGTTCAGAATAATTAAAAGTGAACATTTGGTGCTGAT ACTCAAAAACCTACAAATGTAGCCATTTAAAAAGTAACATGTTTTTCTCCCCTGCTCATTGCCTGGGAGAATGGAATTTTATATAACTAC CTTTCTTTGCAAAAATAACGGTCGTGTCGAGTTGGTGGTGATTTTGGCATTCCATCTTGCACTGGTTTCTAGTATAGGCTTAGAAATAAT TGGTCAGGTAATAATCTTTCCAGTCAAGTTGCAAGGGATGCTTATTTCTCTTCAAAAAAAGACATCCTGCGGGATTGAGTAGAAAATTTT AGGTCAGTTTTGGGTGCTTATTTGTAATATTTTTCCTACTACATTGGAGTTTAGCAGTTCTTTTTTTCTGGATCCAGATACAAGTGTCAT GGTTTATCTTACAGTGGGTGAAACTGACTTTCTTTTGGTTGGGTGGGTGAGGATTTCTTAGGCCTGATAGAATATATATTCTGTGAAGTT TGTTAATGTACATATTAGATTGTATTGGATTTTTTTTTCTTGAATTGCAAATGGTATTATTAGATAGGTTATTTCCAGTTTTACTTCATG ACAAATTACCTAGAGTAAACCTACTTAATACTCCCATGGATTCTATGAAAGTTTAATGGGATCAGAAATTGGTGACTTATAAGGGGGAAG ATATTCTACCATATTTTTATAATAGCTTATTATTCATGTTTCTTGTCTGAAGGACACTCAAGTTACAGAGCAAAATTTCTATAGGTTGAC TAGAATGTTCATAAGCATGGTCTTCCAGTTGCAGGAAAGATCATGTTCTATCTGTGGACACTTACTGTCCTCTACCACAGCTACGTGCCA GAGTTGTTTTCCACAGTTCTTATAAAGGGCATGACTTAGGCTCTTTACCCTCCAACTTAATGTTTATACACAGGGATTGTTTACTAGGTT AATGACATTTAACTCCCCTCTCTTCTGTAGGTGAGAGAAAATAAGTAAGTCTTGATCTGTTTCTTACCAAAGAGAGACAGACCTATGATG GAAAATGATCACGTCTCTGAATTTTTTCTTTAACGTTATAGTTCCTTATTACAGATAGTAAGCATATGGGAATTTCTGAGCTATAACATG TTGAGAAGTTAGAAATTAAAACTAACACAACAAAAGGCGCTGAATCAAAAGATCTTTGCTTTTATTTGGCTCAGAATGTTTTTGGCTTTT CTGCTAAAGATGGCAGAAATTACTCTACACAGACCTGATTTTTCTTTATTGCAGACCATTCTTGTGGGCTTACCCTGAGACTTTTATCCC AATTAGTGAATCTTGGAGGGAATACTTGCTTATTTATGACTTAGGTATTTCCCCCCAAACTTTAATATTCTTGAGCACTTGAAAATACTT TTGAGAAATTTTAACTGTGATTAAATTTAGGTTTATTAGAAATATTCTGTACACATTTGCCTCCATGGTGGCGTAAGTTCTGAAAAATTA TATGACCGTGACAATAGTTTATCATCATCATTATTGTTATTCAAAATAAGGGTAAATAAATCTCTGTATTGCCAAAGTGACTTAAACTGT TCTGATGACCACACAGTGTGATTTCTTTAGCAGAGAAAGTTGGTTTTAAAAATAAATAGTACCACTTTTCTAAGACTGTACAGTTTACAA ATAAGGTTTTTTTCTTTGTTGTTTTCCTCTTCTATTAAGTTTTAGTGAAAAGCCTAATTACAGAAAATTGTGCAGATACTAGTGAAGATA CTAGTATAAGTTTAAAGGAACACGTGACTGTAAAATCTCACATTTACAAAGTGCTTGATCTCTTCATATTTCACACGCATGTTTTAGAAT AGATTTTAGGGAGTGTTTAATTCATTATCCTTTTGACTTAAAATTTTTGTTACCAACTTCCTAGGACTTAGATAATATATAAATAAGTAC AAATCCCAGGGGAAGTGTTGTGATGCTAGACTAAAAGGTGGGAATGTGCTGCTGTTCCGTGAGCCTTGTTCCATTGTTGAAAATTTGATG CCTCAGTGTTTATTCAGTACCACCTCATGGAGCTTCAATGTAAATGGATTATATGTATAATTGGTAATTTGTATAGTTTTGTAGATTGTA GATTAAATGCACTCATCATGTCACATGTAATTGTGCTTGGAGTATTTGTGTTTTATTCTTTTACTTCAACGGGTTCTTGTCTGTTACATC TCTGGTGATTTGAAATATCAGGAAAGACAGTTTGTCAGAAATGAGAATAATATAGTTGAAATCAGTTGGGCTAAAATATTCTACAGCAAG ACAATTTCTTTTGGGTGAACTGATTCTATAATTTACTTACTTTTAATGTAAGGATTAGATTTATTGTTGAGCTGCTTTCCAGATCAGACT GTCACTTTATAGTTTTTCTACATAAAGATTATATAGTTGCAAACAAAGGTTGTGAAATTTCCCTTTTGTTGTTTTTGACTTTTAATTAAT AAAAGTACATTGTTTTCATAGCAAACTTAGACTGTCCATGTAATTTTCTCCATATTGTTTTTCCGATGCAAGCCCAGTTAATAATTAGTT TTTTAGCAGCTTTCTCTCAAGTGAAATAAGTGATGTGACATGTTTATCAGTTATGGCTAAAATGTTACACTTTACATGTTTAAACTATAA >In-frame_ENST00000376911_ENST00000397933_CB132862_ANXA1_chr9_75775236_+_U2SURP_chr3_142769845_length(amino acids)=128AA_start in transcript=1506_stop in transcript=1120 MTWTVSSLYEIFLNALIAPILVMGISLVYHCYCEMGWGMYCVASSFPSLSEYTHLFPSCLWSEIPIFLYLSCLFLVLFLTLSLSLVEEVY -------------------------------------------------------------- >In-frame_ENST00000376911_ENST00000473835_CB132862_ANXA1_chr9_75775236_+_U2SURP_chr3_142769845_length(transcript)=5785nt_BP=1208nt AAAAAAAAAAAAAAAAAAAAAAGCAATCATTAAGCTTTTCATCTAGCCATTACTTTTGTACAGGCTCTCATTAATTCCACATAGATGGTC TAATGGTCTACTAAATAGTATTCTAATCCTCCATCTTGTCTATCTCTTAGCCATTCTCCATGATAAAGGATGAATGGTCTTTCGGAAACA TAAATGAAACCATGCTGCTTTAAAAAAACAAACAAACAAAAAGAAACCCATTAATGTTTTCCCAAAGCTTTGTGGACACATTGAAGCTTC TTGTTTCAGCTTCTGCCAACATTTCTCGCTCCAGCAAACTTTCTTCTGCTTCCCAAATATGACAAGCTTCTTCTTTAACTTTTCTGCCAG GTTAATCTTGACTCATTTCAAGAGAGGCTTGGGTCAGCCAGGGCCTACTCTAAGAAGTTTCTTTAGCCCTTATGTTTTCCTATGGAGAGC ACACACTAGCTTTAAGTCCTGAGGGTACTTAAGATGATATTTCAATGTTTTTGTACTCTTAGTGCTTGGCATATGGTGGGTGGTCTACAA ATTTAGAACAATGTAGTGAACCACAAACTCCTCTCTTCAGCCTGTGTGCTTACTTGTAGTAGTTGTCTGATCTCTAAAATTTAGAACTGA ATATGCCAAGAAAGAGTTCAATTTCAGAGAGGAGGGTATGGTTTCATTTTAAGTATAAAAGCTTCCTTTAAAAAAAATTACGTCTTACAT TTTGTTATGCTCCTAAGTGTAATTGATCCTGGAAAGTAAGCGCAAGGCTACTCTCTAATGCTAACTCTTATGTATGTAAGAGGTGAGGAA GGAGAGGTTGTGTGTGGTGCATTTGTTTTGTAAAAGCATCTAACTGTTTTCTTTCCAGACACTTTTTCAAAAATGGCAATGGTATCAGAA TTCCTCAAGCAGGCCTGGTTTATTGAAAATGAAGAGCAGGAATATGTTCAAACTGTGAAGTCATCCAAAGGTGGTCCCGGATCAGCGGTG AGCCCCTATCCTACCTTCAATCCATCCTCGGATGTCGCTGCCTTGCATAAGGCCATAATGGTTAAAGGTGTGGATGAAGCAACCATCATT GACATTCTAACTAAGCGAAACAATGCACAGCGTCAACAGATCAAAGCAGCATATCTCCAGGAAACAGGAAAGCTCTGCTAAAAACTCCAG CGCAATTTGATGCTGATGAACTTCGTGCTGCCATGAAGTTTTCAGGAGCAAGTAGAACACTACAGAGATAAACTTCTTCAACGAGAGAAA GAGAAAGAGTTAGAAAGAGAACGAGAAAGAGACAAGAAAGATAAAGAAAAATTGGAATCTCGCTCCAAAGACAAGAAGGAAAAAGATGAG TGTACTCCGACAAGGAAGGAAAGGAAGAGGCGACACAGTACATCCCCCAGCCCATCTCGCAGTAGCAGTGGTAGACGAGTGAAATCCCCA TCACCAAAATCGGAGCGATCAGAGCGTTCAGAAAGATCTCATAAAGAGAGCTCACGGTCCAGGTCATCTCACAAAGATTCTCCTAGAGAT GTTAGCAAAAAAGCCAAAAGATCACCATCTGGTTCAAGGACACCTAAAAGGTCTAGGCGATCACGGTCTAGATCTCCTAAAAAATCAGGA AAGAAGTCCAGATCCCAGTCCAGATCTCCACACAGGTCTCATAAAAAGTCAAAGAAAAACAAACACTGACGTAAATTTTTAAGATGCTGT CACTTATTGGAAATGCGATTTGTTTTGTGCCTGAACGGTCTGTTTTTTAAAAAAACAAAAAATCAAATGAAAGAGCATTCCTGGGGTTTT TTGTTTGTTTGTGTATGCATGTGTAAACTCATGAGCAACTGCATCTGTAGATCTGTCATTGTTTTATATTGTGTAAATTACTTTCATTGT GGCTATTTCTCAAGATGAAATTTTTATTGTTCTAATGGATTTCATCAGAAATGTGTATAATGGATCTGCTGACAGTAGTAGTATTTTGTT TTAGGATGTTGTGACTTAGCAAAAATAATACAGATGTCTTCCCCCCTTTTGTAGCTTTGACAATTTGAATTAGATTTCAAATAAAATCTG AACAGAAAACTATAATGTTGTTTTTTTGCCCCACCGGTGATATTAAGTCCCTTAAAGTCCTACTGAGTTTCACACTACTGTTGTGCTTCT TATACCTGATGCACTTTATAAGCCCCAGTGTTCAAGTAGCTTAAGTTTTATATTTACTAAGATGACTATCCAAATTAAGGGACCTGAGAC TCCTATTTGGTGGTTTGCTAACCATTTGCTTTTGATAAGTTTCTCTTGGGTAATACTAATACCCAGATATCAAAGACTAGGTAGATATGG CATGGCGTTTTGTTAGTGGAATGCCTGGCTAAAACATTTTTTTCACAGAAGCAATATGATTTCCATACATCCAACCCATGTTCTGAGCAA CTACTTACTTTTAGGGGGAAATTAAATATCTTTTCATTTCCTCTTCTATTATGAAAGAAGTTTATTTGTAAAACAAATTTTCTAACAAGG TTTGGCCATAGAATTCTCTTGTATGATCGTTGACCTTTTATAATCTTCTGTAGGCTATCTTTCAAACACTGGCATCAGAATATTTTTTAT AAGTTTGTGTTTAAACAGCTTAGTTGGTCCCCCCCCACTCCCAAGAGACTTGGGTTTAGTTATAGCTTTAAGTAAAATTTAAAAATAAAA TGTTTTTCAGGAAACTTCGTATCTAATGGTTTGTAAATTCAAGGTGCAAAAAGTTGATTTAAACCATTTGCAGAGTTGAACTCTATTATG AAAATAAATTTGCTACGGTATGAGGAAGAAATAAAACTTGTGTAATGTTGGTCATAATACTGCTATAAATATAATAAAGGGTTATGTAGA ATTGAACTGACACTATTATTTGTGAATCTTGATTTCAGTTTTTTATGTAGGCACTTCATACACTGGTTTGATGGGTTTTTTTTTTCCTCC CTAAAAGAGAAAGTAGAAAACTATTCTAACAATGGATTATTTTGATTTAGCTTGCTTTTTAAAAAAATCTTTTCAACTTGTTTTACTTAA TCTTGCCTAGTCACAAAATAAGATGTGCACCCATGGTTTGGAGAGTTCCTATATTAGCTGAGCAGTGAGATACACTATTTCCAAACGGTG CACACCTACAGTAGCTTTGGAAATGAGCCAATCACTGTTTTACTTAATGGTTCTTATCAGCATGCAAATATTGCTTGAAAGTTATTTCCT TATTCACTGTTTTGTTAGTCCATTTTGTTAGGAAACATTAATTCCTAAAAATTTGTTCAGAATAATTAAAAGTGAACATTTGGTGCTGAT ACTCAAAAACCTACAAATGTAGCCATTTAAAAAGTAACATGTTTTTCTCCCCTGCTCATTGCCTGGGAGAATGGAATTTTATATAACTAC CTTTCTTTGCAAAAATAACGGTCGTGTCGAGTTGGTGGTGATTTTGGCATTCCATCTTGCACTGGTTTCTAGTATAGGCTTAGAAATAAT TGGTCAGGTAATAATCTTTCCAGTCAAGTTGCAAGGGATGCTTATTTCTCTTCAAAAAAAGACATCCTGCGGGATTGAGTAGAAAATTTT AGGTCAGTTTTGGGTGCTTATTTGTAATATTTTTCCTACTACATTGGAGTTTAGCAGTTCTTTTTTTCTGGATCCAGATACAAGTGTCAT GGTTTATCTTACAGTGGGTGAAACTGACTTTCTTTTGGTTGGGTGGGTGAGGATTTCTTAGGCCTGATAGAATATATATTCTGTGAAGTT TGTTAATGTACATATTAGATTGTATTGGATTTTTTTTTCTTGAATTGCAAATGGTATTATTAGATAGGTTATTTCCAGTTTTACTTCATG ACAAATTACCTAGAGTAAACCTACTTAATACTCCCATGGATTCTATGAAAGTTTAATGGGATCAGAAATTGGTGACTTATAAGGGGGAAG ATATTCTACCATATTTTTATAATAGCTTATTATTCATGTTTCTTGTCTGAAGGACACTCAAGTTACAGAGCAAAATTTCTATAGGTTGAC TAGAATGTTCATAAGCATGGTCTTCCAGTTGCAGGAAAGATCATGTTCTATCTGTGGACACTTACTGTCCTCTACCACAGCTACGTGCCA GAGTTGTTTTCCACAGTTCTTATAAAGGGCATGACTTAGGCTCTTTACCCTCCAACTTAATGTTTATACACAGGGATTGTTTACTAGGTT AATGACATTTAACTCCCCTCTCTTCTGTAGGTGAGAGAAAATAAGTAAGTCTTGATCTGTTTCTTACCAAAGAGAGACAGACCTATGATG GAAAATGATCACGTCTCTGAATTTTTTCTTTAACGTTATAGTTCCTTATTACAGATAGTAAGCATATGGGAATTTCTGAGCTATAACATG TTGAGAAGTTAGAAATTAAAACTAACACAACAAAAGGCGCTGAATCAAAAGATCTTTGCTTTTATTTGGCTCAGAATGTTTTTGGCTTTT CTGCTAAAGATGGCAGAAATTACTCTACACAGACCTGATTTTTCTTTATTGCAGACCATTCTTGTGGGCTTACCCTGAGACTTTTATCCC AATTAGTGAATCTTGGAGGGAATACTTGCTTATTTATGACTTAGGTATTTCCCCCCAAACTTTAATATTCTTGAGCACTTGAAAATACTT TTGAGAAATTTTAACTGTGATTAAATTTAGGTTTATTAGAAATATTCTGTACACATTTGCCTCCATGGTGGCGTAAGTTCTGAAAAATTA TATGACCGTGACAATAGTTTATCATCATCATTATTGTTATTCAAAATAAGGGTAAATAAATCTCTGTATTGCCAAAGTGACTTAAACTGT TCTGATGACCACACAGTGTGATTTCTTTAGCAGAGAAAGTTGGTTTTAAAAATAAATAGTACCACTTTTCTAAGACTGTACAGTTTACAA ATAAGGTTTTTTTCTTTGTTGTTTTCCTCTTCTATTAAGTTTTAGTGAAAAGCCTAATTACAGAAAATTGTGCAGATACTAGTGAAGATA CTAGTATAAGTTTAAAGGAACACGTGACTGTAAAATCTCACATTTACAAAGTGCTTGATCTCTTCATATTTCACACGCATGTTTTAGAAT AGATTTTAGGGAGTGTTTAATTCATTATCCTTTTGACTTAAAATTTTTGTTACCAACTTCCTAGGACTTAGATAATATATAAATAAGTAC AAATCCCAGGGGAAGTGTTGTGATGCTAGACTAAAAGGTGGGAATGTGCTGCTGTTCCGTGAGCCTTGTTCCATTGTTGAAAATTTGATG CCTCAGTGTTTATTCAGTACCACCTCATGGAGCTTCAATGTAAATGGATTATATGTATAATTGGTAATTTGTATAGTTTTGTAGATTGTA GATTAAATGCACTCATCATGTCACATGTAATTGTGCTTGGAGTATTTGTGTTTTATTCTTTTACTTCAACGGGTTCTTGTCTGTTACATC TCTGGTGATTTGAAATATCAGGAAAGACAGTTTGTCAGAAATGAGAATAATATAGTTGAAATCAGTTGGGCTAAAATATTCTACAGCAAG ACAATTTCTTTTGGGTGAACTGATTCTATAATTTACTTACTTTTAATGTAAGGATTAGATTTATTGTTGAGCTGCTTTCCAGATCAGACT GTCACTTTATAGTTTTTCTACATAAAGATTATATAGTTGCAAACAAAGGTTGTGAAATTTCCCTTTTGTTGTTTTTGACTTTTAATTAAT >In-frame_ENST00000376911_ENST00000473835_CB132862_ANXA1_chr9_75775236_+_U2SURP_chr3_142769845_length(amino acids)=128AA_start in transcript=1506_stop in transcript=1120 MTWTVSSLYEIFLNALIAPILVMGISLVYHCYCEMGWGMYCVASSFPSLSEYTHLFPSCLWSEIPIFLYLSCLFLVLFLTLSLSLVEEVY -------------------------------------------------------------- >In-frame_ENST00000376911_ENST00000493598_CB132862_ANXA1_chr9_75775236_+_U2SURP_chr3_142769845_length(transcript)=2085nt_BP=1208nt AAAAAAAAAAAAAAAAAAAAAAGCAATCATTAAGCTTTTCATCTAGCCATTACTTTTGTACAGGCTCTCATTAATTCCACATAGATGGTC TAATGGTCTACTAAATAGTATTCTAATCCTCCATCTTGTCTATCTCTTAGCCATTCTCCATGATAAAGGATGAATGGTCTTTCGGAAACA TAAATGAAACCATGCTGCTTTAAAAAAACAAACAAACAAAAAGAAACCCATTAATGTTTTCCCAAAGCTTTGTGGACACATTGAAGCTTC TTGTTTCAGCTTCTGCCAACATTTCTCGCTCCAGCAAACTTTCTTCTGCTTCCCAAATATGACAAGCTTCTTCTTTAACTTTTCTGCCAG GTTAATCTTGACTCATTTCAAGAGAGGCTTGGGTCAGCCAGGGCCTACTCTAAGAAGTTTCTTTAGCCCTTATGTTTTCCTATGGAGAGC ACACACTAGCTTTAAGTCCTGAGGGTACTTAAGATGATATTTCAATGTTTTTGTACTCTTAGTGCTTGGCATATGGTGGGTGGTCTACAA ATTTAGAACAATGTAGTGAACCACAAACTCCTCTCTTCAGCCTGTGTGCTTACTTGTAGTAGTTGTCTGATCTCTAAAATTTAGAACTGA ATATGCCAAGAAAGAGTTCAATTTCAGAGAGGAGGGTATGGTTTCATTTTAAGTATAAAAGCTTCCTTTAAAAAAAATTACGTCTTACAT TTTGTTATGCTCCTAAGTGTAATTGATCCTGGAAAGTAAGCGCAAGGCTACTCTCTAATGCTAACTCTTATGTATGTAAGAGGTGAGGAA GGAGAGGTTGTGTGTGGTGCATTTGTTTTGTAAAAGCATCTAACTGTTTTCTTTCCAGACACTTTTTCAAAAATGGCAATGGTATCAGAA TTCCTCAAGCAGGCCTGGTTTATTGAAAATGAAGAGCAGGAATATGTTCAAACTGTGAAGTCATCCAAAGGTGGTCCCGGATCAGCGGTG AGCCCCTATCCTACCTTCAATCCATCCTCGGATGTCGCTGCCTTGCATAAGGCCATAATGGTTAAAGGTGTGGATGAAGCAACCATCATT GACATTCTAACTAAGCGAAACAATGCACAGCGTCAACAGATCAAAGCAGCATATCTCCAGGAAACAGGAAAGCTCTGCTAAAAACTCCAG CGCAATTTGATGCTGATGAACTTCGTGCTGCCATGAAGTTTTCAGGAGCAAGTAGAACACTACAGAGATAAACTTCTTCAACGAGAGAAA GAGAAAGAGTTAGAAAGAGAACGAGAAAGAGACAAGAAAGATAAAGAAAAATTGGAATCTCGCTCCAAAGACAAGAAGGAAAAAGATGAG TGTACTCCGACAAGGAAGGAAAGGAAGAGGCGACACAGTACATCCCCCAGCCCATCTCGCAGTAGCAGTGGTAGACGAGTGAAATCCCCA TCACCAAAATCGGAGCGATCAGAGCGTTCAGAAAGATCTCATAAAGAGAGCTCACGGTCCAGGTCATCTCACAAAGATTCTCCTAGAGAT GTTAGCAAAAAAGCCAAAAGATCACCATCTGGTTCAAGGACACCTAAAAGGTCTAGGCGATCACGGTCTAGATCTCCTAAAAAATCAGGA AAGAAGTCCAGATCCCAGTCCAGATCTCCACACAGGTCTCATAAAAAGTCAAAGAAAAACAAACACTGACGTAAATTTTTAAGATGCTGT CACTTATTGGAAATGCGATTTGTTTTGTGCCTGAACGGTCTGTTTTTTAAAAAAACAAAAAATCAAATGAAAGAGCATTCCTGGGGTTTT TTGTTTGTTTGTGTATGCATGTGTAAACTCATGAGCAACTGCATCTGTAGATCTGTCATTGTTTTATATTGTGTAAATTACTTTCATTGT GGCTATTTCTCAAGATGAAATTTTTATTGTTCTAATGGATTTCATCAGAAATGTGTATAATGGATCTGCTGACAGTAGTAGTATTTTGTT TTAGGATGTTGTGACTTAGCAAAAATAATACAGATGTCTTCCCCCCTTTTGTAGCTTTGACAATTTGAATTAGATTTCAAATAAAATCTG >In-frame_ENST00000376911_ENST00000493598_CB132862_ANXA1_chr9_75775236_+_U2SURP_chr3_142769845_length(amino acids)=128AA_start in transcript=1506_stop in transcript=1120 MTWTVSSLYEIFLNALIAPILVMGISLVYHCYCEMGWGMYCVASSFPSLSEYTHLFPSCLWSEIPIFLYLSCLFLVLFLTLSLSLVEEVY -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for ANXA1-U2SURP |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for ANXA1-U2SURP |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Hgene | ANXA1 | P04083 | DB00288 | Amcinonide | Agonist | Small molecule | Approved |
Hgene | ANXA1 | P04083 | DB00288 | Amcinonide | Agonist | Small molecule | Approved |
Hgene | ANXA1 | P04083 | DB00288 | Amcinonide | Agonist | Small molecule | Approved |
Hgene | ANXA1 | P04083 | DB01013 | Clobetasol propionate | Inducer | Small molecule | Approved |
Hgene | ANXA1 | P04083 | DB01013 | Clobetasol propionate | Inducer | Small molecule | Approved |
Hgene | ANXA1 | P04083 | DB01013 | Clobetasol propionate | Inducer | Small molecule | Approved |
Hgene | ANXA1 | P04083 | DB01222 | Budesonide | Substrate | Small molecule | Approved |
Hgene | ANXA1 | P04083 | DB01222 | Budesonide | Substrate | Small molecule | Approved |
Hgene | ANXA1 | P04083 | DB01222 | Budesonide | Substrate | Small molecule | Approved |
Hgene | ANXA1 | P04083 | DB00591 | Fluocinolone acetonide | Inducer | Small molecule | Approved|Investigational|Vet_approved |
Hgene | ANXA1 | P04083 | DB00591 | Fluocinolone acetonide | Inducer | Small molecule | Approved|Investigational|Vet_approved |
Hgene | ANXA1 | P04083 | DB00591 | Fluocinolone acetonide | Inducer | Small molecule | Approved|Investigational|Vet_approved |
Hgene | ANXA1 | P04083 | DB01234 | Dexamethasone | Agonist | Small molecule | Approved|Investigational|Vet_approved |
Hgene | ANXA1 | P04083 | DB01234 | Dexamethasone | Agonist | Small molecule | Approved|Investigational|Vet_approved |
Hgene | ANXA1 | P04083 | DB01234 | Dexamethasone | Agonist | Small molecule | Approved|Investigational|Vet_approved |
Hgene | ANXA1 | P04083 | DB14541 | Hydrocortisone cypionate | Small molecule | Approved|Investigational|Vet_approved | |
Hgene | ANXA1 | P04083 | DB14541 | Hydrocortisone cypionate | Small molecule | Approved|Investigational|Vet_approved | |
Hgene | ANXA1 | P04083 | DB14541 | Hydrocortisone cypionate | Small molecule | Approved|Investigational|Vet_approved | |
Hgene | ANXA1 | P04083 | DB14649 | Dexamethasone acetate | Agonist | Small molecule | Approved|Investigational|Vet_approved |
Hgene | ANXA1 | P04083 | DB14649 | Dexamethasone acetate | Agonist | Small molecule | Approved|Investigational|Vet_approved |
Hgene | ANXA1 | P04083 | DB14649 | Dexamethasone acetate | Agonist | Small molecule | Approved|Investigational|Vet_approved |
Hgene | ANXA1 | P04083 | DB00741 | Hydrocortisone | Agonist | Small molecule | Approved|Vet_approved |
Hgene | ANXA1 | P04083 | DB00741 | Hydrocortisone | Agonist | Small molecule | Approved|Vet_approved |
Hgene | ANXA1 | P04083 | DB00741 | Hydrocortisone | Agonist | Small molecule | Approved|Vet_approved |
Hgene | ANXA1 | P04083 | DB00959 | Methylprednisolone | Agonist | Small molecule | Approved|Vet_approved |
Hgene | ANXA1 | P04083 | DB00959 | Methylprednisolone | Agonist | Small molecule | Approved|Vet_approved |
Hgene | ANXA1 | P04083 | DB00959 | Methylprednisolone | Agonist | Small molecule | Approved|Vet_approved |
Hgene | ANXA1 | P04083 | DB14539 | Hydrocortisone acetate | Small molecule | Approved|Vet_approved | |
Hgene | ANXA1 | P04083 | DB14539 | Hydrocortisone acetate | Small molecule | Approved|Vet_approved | |
Hgene | ANXA1 | P04083 | DB14539 | Hydrocortisone acetate | Small molecule | Approved|Vet_approved | |
Hgene | ANXA1 | P04083 | DB14540 | Hydrocortisone butyrate | Small molecule | Approved|Vet_approved | |
Hgene | ANXA1 | P04083 | DB14540 | Hydrocortisone butyrate | Small molecule | Approved|Vet_approved | |
Hgene | ANXA1 | P04083 | DB14540 | Hydrocortisone butyrate | Small molecule | Approved|Vet_approved | |
Hgene | ANXA1 | P04083 | DB14542 | Hydrocortisone phosphate | Small molecule | Approved|Vet_approved | |
Hgene | ANXA1 | P04083 | DB14542 | Hydrocortisone phosphate | Small molecule | Approved|Vet_approved | |
Hgene | ANXA1 | P04083 | DB14542 | Hydrocortisone phosphate | Small molecule | Approved|Vet_approved | |
Hgene | ANXA1 | P04083 | DB14543 | Hydrocortisone probutate | Small molecule | Approved|Vet_approved | |
Hgene | ANXA1 | P04083 | DB14543 | Hydrocortisone probutate | Small molecule | Approved|Vet_approved | |
Hgene | ANXA1 | P04083 | DB14543 | Hydrocortisone probutate | Small molecule | Approved|Vet_approved | |
Hgene | ANXA1 | P04083 | DB14544 | Hydrocortisone valerate | Small molecule | Approved|Vet_approved | |
Hgene | ANXA1 | P04083 | DB14544 | Hydrocortisone valerate | Small molecule | Approved|Vet_approved | |
Hgene | ANXA1 | P04083 | DB14544 | Hydrocortisone valerate | Small molecule | Approved|Vet_approved | |
Hgene | ANXA1 | P04083 | DB14631 | Prednisolone phosphate | Ligand | Small molecule | Approved|Vet_approved |
Hgene | ANXA1 | P04083 | DB14631 | Prednisolone phosphate | Ligand | Small molecule | Approved|Vet_approved |
Hgene | ANXA1 | P04083 | DB14631 | Prednisolone phosphate | Ligand | Small molecule | Approved|Vet_approved |
Hgene | ANXA1 | P04083 | DB14669 | Betamethasone phosphate | Agonist | Small molecule | Approved|Vet_approved |
Hgene | ANXA1 | P04083 | DB14669 | Betamethasone phosphate | Agonist | Small molecule | Approved|Vet_approved |
Hgene | ANXA1 | P04083 | DB14669 | Betamethasone phosphate | Agonist | Small molecule | Approved|Vet_approved |
Hgene | ANXA1 | P04083 | DB14538 | Hydrocortisone aceponate | Small molecule | Experimental|Vet_approved | |
Hgene | ANXA1 | P04083 | DB14538 | Hydrocortisone aceponate | Small molecule | Experimental|Vet_approved | |
Hgene | ANXA1 | P04083 | DB14538 | Hydrocortisone aceponate | Small molecule | Experimental|Vet_approved |
Top |
Related Diseases for ANXA1-U2SURP |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | ANXA1 | C0024667 | Animal Mammary Neoplasms | 3 | CTD_human |
Hgene | ANXA1 | C1257925 | Mammary Carcinoma, Animal | 3 | CTD_human |
Hgene | ANXA1 | C0007097 | Carcinoma | 2 | CTD_human |
Hgene | ANXA1 | C0024668 | Mammary Neoplasms, Experimental | 2 | CTD_human |
Hgene | ANXA1 | C0205696 | Anaplastic carcinoma | 2 | CTD_human |
Hgene | ANXA1 | C0205697 | Carcinoma, Spindle-Cell | 2 | CTD_human |
Hgene | ANXA1 | C0205698 | Undifferentiated carcinoma | 2 | CTD_human |
Hgene | ANXA1 | C0205699 | Carcinomatosis | 2 | CTD_human |
Hgene | ANXA1 | C0007137 | Squamous cell carcinoma | 1 | CTD_human |
Hgene | ANXA1 | C0020538 | Hypertensive disease | 1 | CTD_human |
Hgene | ANXA1 | C0022658 | Kidney Diseases | 1 | CTD_human |
Hgene | ANXA1 | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
Hgene | ANXA1 | C0024232 | Lymphatic Metastasis | 1 | CTD_human |
Hgene | ANXA1 | C0026640 | Mouth Neoplasms | 1 | CTD_human |
Hgene | ANXA1 | C0027626 | Neoplasm Invasiveness | 1 | CTD_human |
Hgene | ANXA1 | C0027627 | Neoplasm Metastasis | 1 | CTD_human |
Hgene | ANXA1 | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
Hgene | ANXA1 | C0038354 | Stomach Diseases | 1 | CTD_human |
Hgene | ANXA1 | C0152013 | Adenocarcinoma of lung (disorder) | 1 | CTD_human |
Hgene | ANXA1 | C0153381 | Malignant neoplasm of mouth | 1 | CTD_human |
Hgene | ANXA1 | C0279626 | Squamous cell carcinoma of esophagus | 1 | CTD_human |
Hgene | ANXA1 | C0376358 | Malignant neoplasm of prostate | 1 | CTD_human |
Hgene | ANXA1 | C0376634 | Craniofacial Abnormalities | 1 | CTD_human |
Tgene | U2SURP | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |